The United States has experienced extraordinary gains in treating cardiovascular disease over the last few decades. Statins, introduced in the 1980’s, are an important part of the story. Hundreds of thousands of deaths, heart attacks, and strokes have
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/09/30/moving-beyond-price-per-dose-in-the-pharmaceutical-industry/
Posted
Sep 30 2015, 09:36 AM
by
Health Affairs Blog
Filed under: Public Health, Physicians, Pharma, Quality, Population Health, Organization and Delivery, Costs and Spending, Drugs and Medical Technology, Health Professionals, patients, statins, cholesterol, cardiovascular